Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Tam

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Scientific Reports|April 27, 2021
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulationElla Fung, Liya Kang, Diana Sapashnik, et al.
Peptides|April 1, 2006
A novel approach to identifying beta-secretase inhibitors: bis-statine peptide mimetics discovered using structure and spot synthesisKristie Grove Bridges, Rajiv Chopra, Laura Lin, et al.
Brain : a Journal of Neurology|February 5, 2026
Diagnostic yield of genome sequencing in children with progressive movement disordersLuca Schierbaum, Enrique Gonzalez Saez-Diez, Amy Tam, et al.
Journal of Medicinal Chemistry|July 30, 2010
Identification and characterization of acidic mammalian chitinase inhibitorsDerek C Cole, Andrea M Olland, Jaison Jacob, et al.
Mabs|December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokineticsLindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Scientific Reports|March 11, 2018
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous DosingYan Weng, Tetsuya Ishino, Annette Sievers, et al.
Journal of Biotechnology|November 7, 2022
Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activationXiaotian Zhong, Jennifer Schenk, Paul Sakorafas, et al.
Brain : a Journal of Neurology|May 5, 2026
Genotype-structure-phenotype correlations define divergent natural history in early-onset spastic paraplegia type 4Julian E Alecu, Luca M Schierbaum, Amy Tam, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2026
The Movement Disorder Spectrum of ATP1A3-Related Disorders: Cross-Sectional Analysis and Video Archive of 88 PatientsKaterina Bernardi, Anna Zhou, Kathryn Yang, et al.
Genome Biology|January 22, 2025
MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assaysAlan F Rubin, Jeremy Stone, Aisha Haley Bianchi, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Scientific Reports|April 27, 2021
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulationElla Fung, Liya Kang, Diana Sapashnik, et al.
Peptides|April 1, 2006
A novel approach to identifying beta-secretase inhibitors: bis-statine peptide mimetics discovered using structure and spot synthesisKristie Grove Bridges, Rajiv Chopra, Laura Lin, et al.
Brain : a Journal of Neurology|February 5, 2026
Diagnostic yield of genome sequencing in children with progressive movement disordersLuca Schierbaum, Enrique Gonzalez Saez-Diez, Amy Tam, et al.
Journal of Medicinal Chemistry|July 30, 2010
Identification and characterization of acidic mammalian chitinase inhibitorsDerek C Cole, Andrea M Olland, Jaison Jacob, et al.
Mabs|December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokineticsLindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Scientific Reports|March 11, 2018
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous DosingYan Weng, Tetsuya Ishino, Annette Sievers, et al.
Journal of Biotechnology|November 7, 2022
Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activationXiaotian Zhong, Jennifer Schenk, Paul Sakorafas, et al.
Brain : a Journal of Neurology|May 5, 2026
Genotype-structure-phenotype correlations define divergent natural history in early-onset spastic paraplegia type 4Julian E Alecu, Luca M Schierbaum, Amy Tam, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2026
The Movement Disorder Spectrum of ATP1A3-Related Disorders: Cross-Sectional Analysis and Video Archive of 88 PatientsKaterina Bernardi, Anna Zhou, Kathryn Yang, et al.
Genome Biology|January 22, 2025
MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assaysAlan F Rubin, Jeremy Stone, Aisha Haley Bianchi, et al.
Pageof 5